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Introduction 
The proper clinical diagnosis of neurodegenerative diseases is often difficult given the 
large overlap in signs and symptoms. In the clinical practice, physicians focus on signs and 
symptoms and their progression; the classification systems of diseases is based on expert 
consensus bearing the sign of subjectivity, and we have to face with the fact that definitive 
biomarkers are still missing from the everyday practice. One possible solution is the 
standardized application of neuropsychological tests measuring the functional integrity of 
neuronal circuits, possibly with markers from peripheral blood and brain imaging. In this, 
thesis we describe a series of experiments, which were designed to achieve this general aim. 
From a neuroanatomical point of view, we investigated three disorders: (1) Parkinson’s 
disease (PD) with a marked impairment of frontostriatal circuits mediating motor control, 
cognition, and emotions; (2) early Alzheimer’s disease (AD) associated with medial temporal 
lobe pathology; (3) frontotemporal dementia (FTD) with behavioural symptoms and executive 
dysfunctions. 
 
Our specific aims were as follows: 
1. We investigated young, never-medicated patients with PD and a matched sample of 
PD patients who were on dopamine agonist therapy. We followed-up the never-medicated 
sample after the initiation of dopamine agonists pramipexole or ropinirole (longitudinal, 
within-subject part of the study). We used a feedback-based probabilistic classification 
learning task that enabled us to investigate stimulus-response learning guided by positive and 
negative feedback (winning and losing virtual money). Results from this feedback-based task 
were compared with personality traits as measured by the Temperament and Character 
Inventory (TCI). Specifically, we were interested in novelty seeking and harm avoidance in 
unmedicated and medicated PD patients and their relationship with reward and punishment 
learning. 
 2. We investigated feedback-guided stimulus-response learning in early AD and tested 
the generalization and flexibility of these associations. The data analysis was focused on 
acquired equivalence and on the retrieval of associations in a free task context (non-directed 
card pairing) instead of instrumental responding. 
3. The third specific aim was to test the discriminative power of the clock-drawing test 
(CDT) regarding AD vs. FTD. The aim of our study was to examine both overall and specific 
error differences. We only examined the command condition of the CDT, because it is a more 
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sensitive and cognitively demanding measure compared to the copy condition. The data 
analysis was focused on errors related to visuospatial difficulties and conceptual problems, as 
visuospatial skill can be relatively preserved in FTD patients, and AD patients are expected to 
display more conceptual errors. 
 
Methods 
 Participants 
 1. The clinical and demographic data of PD patients are shown in Table 1. The mean 
dose of pramipexole (n=12) was 4.5 mg/day (range: 2.5-6.0 mg/day), the mean dose of 
ropinirole (n=10) was 5.5 mg/day (range: 2.0-7.0 mg/day). After baseline testing, never-
medicated PD patients started dopamine agonist therapy and were followed-up for 12 weeks 
(pramipexole: n=14, mean dose at follow-up: 4.0 mg/day, range 2.0-6.0 mg/day; ropinirole: 
n=12, mean dose at follow-up: 5.5 mg/day, range: 2.0-7.5 mg/day). After this period, 
participants were re-evaluated. 
Table 1. Clinical and demographic characteristics of the participants 
 Controls Never medicated 
Parkinson’s 
disease 
Recently 
medicated 
Parkinson’s 
disease 
Number of 
participants 
(male/female) 
20 (15/5) 26 (18/8) 22 (17/5) 
Age (years) 45.3 (8.5) 44.8 (5.2) 45.3 (8.2) 
Education (years) 13.7 (4.8) 13.3 (5.4) 14.4 (6.2) 
Months since 
diagnosis* 
– 3.2 (2.0) 8.8 (3.5) 
Full-scale IQ (WAIS-
R) 
108.3 (10.0) 109.6 (11.7) 108.0 (13.9) 
Socio-economic 
status 
(Hollingshead) 
34.6 (13.0) 35.6 (14.7) 33.9 (16.8) 
Novelty seeking* 20.8 (3.2) 17.0 (4.2) 25.0 (7.4) 
Harm avoidance 15.8 (4.0) 15.5 (3.1) 15.5 (3.3) 
Reward dependence 16.1 (4.4) 17.3 (4.2) 17.4 (4.1) 
Persistence 4.2 (0.8) 4.0 (1.0) 4.1 (1.1) 
No. of patients in 
Hoehn–Yahr Stage 
– 1.0:4 
1.5:2 
2:18 
2.5:1 
3:1 
1.0:2 
1.5:2 
2:15 
2.5:2 
3:1 
UPDRS – 30.8 (6.4) 27.5 (6.1) 
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HAM-D – 4.2 (1.4) 4.6 (2.0) 
HAM-A – 3.1 (1.8) 3.3 (1.5) 
Data are mean (standard deviation). *Significant difference across group, P<0.05. UPDRS Unified Parkinson’s 
Disease Rating Scale. HAM-D Hamilton Depression Rating Scale. HAM-A Hamilton Anxiety Rating Scale. 
WAIS-R Wechsler Adult Intelligence Scale. 
2. The clinical and demographical data of AD patients are shown in Table 2. 
The diagnosis of probable AD was made according to the National Institute of Neurological 
and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders 
Association (NINCDS-ADRDA) criteria. Exclusion criteria consisted of vascular lesions on 
MRI scans and prior neurological and psychiatric disorders. 
Table 2. Clinical and demographical characteristics of the participants 
 Controls (n=20) Alzheimer’s patients (n=22) 
Age (years) 70.1 (4.8) 69.8 (6.9) 
Male/female 12/8 15/7 
Education (years) 13.7 (3.2) 13.6 (3.8) 
MMSE 29.4 (0.7) 24.0 (1.3) 
GDS - 3.7 (0.5) 
There were no significant differences between controls and Alzheimer’s patients with the exception of the Mini-
Mental State Examination (MMSE) scores (p<0.0001). GDS Global Deterioration Scale. 
3. Table 3 represents the characteristics FTD and AD patients. The FTD group was 
composed of frontotemporal dementia behavioral variant (FTD-bv) (n=18), primer non-fluent 
aphasia (PNFA) (n=13), and semantic dementia (SD) (n=5) patients. The AD patients all met 
the criteria for probable Alzheimer’s disease according to the NINCDS-ADRDA criteria. The 
FTD sample fulfilled the Neary and McKhann criteria. The PNFA group included patients 
who were anomic, logopenic, and nonfluent. The SD group was diagnosed by the presence of 
a prominent comprehension deficit, naming difficulty, and asking the meaning of nouns and 
objects. 
Table 3. Demographic characteristics, cognitive test results, and overall CDT scores of participants 
 FTD 
(n=36) 
M (SD) 
AD 
(n=25) 
M (SD) 
Controls 
(n=25) 
M (SD) 
Total 
Population 
(N=86) 
M (SD) 
 
p value 
 
Age (yrs) 65.14 (7.66) 78.76 (6.04) 65.36 (3.96) 69.16 (8.78) b<.001 
 
Education 
(yrs) 
13.64 (3.74) 11.88 (4.77) 12.12 (2.93) 12.69 (3.9) .17 
Duration of 
illness (yrs) 
3.83 (2.02) 3.42 (2.12)   .45 
 
Gender 
(F:M) 
18:18 10:15 13:12 41:45 .65 
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MMSE 
(maximum 
30) 
24.22 (3.98) 22.12 (1.92) 28.84 (1.07) 24.95 (3.86) c<.001 
 
DRS-2 
(maximum 
144) 
113.21 
(20.23) 
113.25 
(11.55) 
139.44 (3.59) 121.63 
(18.94) 
a<.001 
 
CDT 
(maximum 
10) 
7.74 (1.99) 5.48 (2.36) 9.54 (.58) 7.6 (2.4) c<.001 
 
Note. AD Alzheimer’s disease, FTD Frontotemporal dementia. MMSE Mini-Mental State Examination. DRS-2 
Dementia Rating Scale. a controls versus FTD, controls versus AD; b AD versus controls, AD versus FTD; c 
FTD versus controls, FTD versus AD, controls versus AD. 
Neuropsychological Tasks 
 1. In the reinforcement learning experiment, participants were administered a 
computer-based probabilistic classification task. On each trial, participants viewed one of four 
images, and were asked to guess whether it belonged to category A or category B. For each 
participant, the four images were randomly assigned to be stimuli S1, S2, S3, and S4. A 
second set of similar images (S5-S8) were used for repeated testing. On any given trial, 
stimuli S1 and S3 belonged to category A with 80% probability and to category B with 20% 
probability, while stimuli S2 and S4 belonged to category B with 80% probability and to 
category A with 20% probability. Stimuli S1 and S2 were used in the reward-learning task. 
Thus, if the participant correctly guessed category membership on a trial with either of these 
stimuli, a reward of +25 points was received; if the participant guessed incorrectly, no 
feedback appeared. Stimuli S3 and S4 were used in the punishment-learning task. Thus, if the 
participant guessed incorrectly on a trial with either of these stimuli, a punishment of –25 was 
received; correct guesses received no feedback. The task contained 160 trials. On each trial, 
the computer recorded whether the participant made the optimal response (i.e. category A for 
S1 and S3, and category B for S2 and S4) regardless of actual outcome. 
 Following the probabilistic classification task, all participants were administered the 
Hungarian version of the Temperament and Character Inventory (TCI) questionnaire, which 
has a good test-retest reliability. In this study, we focused on the temperament traits of novelty 
seeking, harm avoidance, and reward dependence, and persistence. Thus, in addition to the 
main focus on novelty seeking and harm avoidance, data also were collected on reward 
dependence and persistence in order to test the specificity of possible alterations in personality 
traits. 
 2. In the associative learning task (Figure 1) the antecedent stimuli were four 
drawings of faces (man, woman, girl, boy). The consequents were drawings of fish colored 
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red, orange, purple, and pink. For each participant, stimuli were randomly assigned as 
antecedent and consequent stimuli. On each trial, a face and two fish drawings were displayed 
on the computer screen along with the prompt: “Which fish does this person have? Use the 
Left or Right key to choose”. The participant responded with pressing one of two separate 
keys labeled as “LEFT” and “RIGHT” to indicate whether the fish on the left or the fish on 
the right was associated with the face. The selected fish drawing was circled and corrective 
feedback was given. In the case of an incorrect response, an alert beep sounded. There were 
three stages in the acquisition phase. Stages 1 and 2 terminated after 8 consecutive correct 
responses, whereas stage 3 terminated after 12 consecutive correct responses. The participant 
was not informed on the beginning of a new stage. After the termination of the acquisition 
phase, a new instruction appeared on the screen, informing the participant that the task would 
remain the same but feedback would no longer be provided. The participant was not informed 
of the presence of new associations. The transfer phase consisted of 48 trials of which 12 
trials were new associations for the testing of learned equivalence and 36 trials were old 
associations trained during the acquisition phase. The dependent measures were the mean 
number of errors in the acquisition phase and the proportion of incorrect responses in the 
transfer phase. 
Figure 4. Example screen events during one trial. (A) Stimuli appear. (B) Participant responds and corrective 
feedback is given. 
 
 
Which fish does this person have?
Use "Left" or "Right" key to choose.
Which fish does this person have?
Use "Left" or "Right" key to choose.
Correct!
Which fish does this person have?
Use "Left" or "Right" key to choose.
Which fish does this person have?
Use "Left" or "Right" key to choose.
A
B
Correct!
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 3. In the visuospatial assessment, after receiving a pencil and a blank sheet of paper, 
participants were told to draw a clock, put in all the numbers, and set the hands for 10 after 
11. The drawings were analyzed by two judges who were blinded to the diagnosis and identity 
of each individual in our study. 
The judges followed the quantitative (overall) scoring system, set out by Rouleau et al, 
with a maximum of 10 points. It was designed to examine the clock face (maximum, 2 
points), layout of numbers (maximum, 4 points), and the position of the hands (maximum, 4 
points). The average score of the raters was used in the analysis. Qualitative error scoring was 
done according to six error types also employed by Rouleau et al.: (1) clock sizes that are 
either large (greater than 12.7 cm) or small (less than 3.81 cm); (2) graphic difficulties such as 
distortions in the clock face, hands or a general clumsy performance; (3) stimulus-bound 
responses that are either pure (also known as the “frontal pull” response), where the hands are 
set to 10 to 11 instead of 10 after 11; or other types of stimulus bound responses that are also 
rated as conceptual errors, such as the time written on the clock, absent hands or hands 
pointed to 10 or 11; (4) conceptual deficits that include misrepresentation of the time, such as 
the hands are absent or inadequately displayed; or misrepresentation of the clock face, such as 
a clock without numbers or the inappropriate use of numbers; (5) spatial or planning deficits 
that include neglect of the left half of the clock, gaps between numbers, numbers outside the 
clock, and counterclockwise layout of numbers; and (6) perseveration of hands or numbers. A 
qualitative error was considered present only if both judges agreed on its presence. 
Data analysis 
The STATISTICA 7.0 software was used for data analysis. Kolmogorov-Smirnov tests were 
used to check the normality of data distribution. Data were then analyzed with mixed-model, 
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repeated measures analyses of variance (ANOVAs), followed by post hoc tests (Tukey’s HSD 
test or Scheffé’s test). Pearson’s or Spearman’s correlation coefficients were calculated 
among variables. The level of statistical significance was p<0.05 (Bonferroni corrected where 
appropriate). 
 
Results 
1. Reward and punishment learning in PD (in a cross-sectional design comparing 
medicated and unmedicated patients- and in a longitudinal design -comparing patients before 
and after medication). The never-medicated PD patients displayed significantly impaired 
performance on reward learning as compared with the controls, whereas the opposite effect 
was found for punishment learning: the patients outperformed the controls. When the 
recently-medicated PD patients were compared with the controls, there was no significant 
difference for reward learning, but the patients displayed significantly impaired performance 
on punishment learning. Finally, when the recently-medicated and the never-medicated PD 
patients were compared, we found that the recently-medicated group outperformed the never-
medicated group in the reward condition, whereas the opposite was found in the punishment 
condition (Figure 2). 
Figure 2. Results from the feedback-based probabilistic classification task at baseline and at follow-up when 
Parkinson’s patients (PD) received pramipexole and ropinirole. In reward learning, performance in the 
unmedicated baseline condition was significantly worse than in the medicated follow-up condition, whereas in 
punishment learning, performance in the unmedicated condition was significantly better than in the medicated 
condition (p<0.001). Data are mean, error bars indicate standard errors. 
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2. Personality traits in PD. The never-medicated PD patients exhibited significantly 
lower novelty seeking scores compared with controls and with recently-medicated patients. In 
addition, the recently-medicated patients exhibited significantly higher novelty seeking scores 
compared with the controls. In the healthy control group, there was a significant positive 
relationship between the percent of optimal choices on the feedback-based task for positive 
feedback (reward) and novelty seeking scores. A similar tendency was observed in never-
medicated PD patients, but this did not reach the level of statistical significance. We observed 
the strongest positive correlation in recently-medicated PD patients (Figure 3). In the healthy 
control group, we also observed a significant positive correlation between the percent of 
optimal choices on the feedback-based task for negative feedback (punishment) and harm 
avoidance scores, which also was present in never-medicated PD patients but not in recently-
medicated patients. When the correlation analysis was corrected for multiple comparisons 
(Bonferroni, alpha adjusted to 0.002), only the correlation between novelty seeking and 
reward learning in the recently-medicated PD group, and the correlation between harm 
avoidance and punishment learning in the controls reached the level of significance. 
Dopaminergic medications significantly increased novelty seeking, whereas harm avoidance 
and reward dependence did not change significantly. This was not accompanied by clinical 
changes in mood and anxiety, because HAM-D and HAM-A scores were similar at the 
baseline and at the follow-up assessment. 
Figure 3. Correlations between novelty seeking and reward learning in recently-medicated patients (red) 
 
3. Flexibility and generalization of stimulus-response associations in AD. Patients 
with AD committed more errors compared with controls. Tukey HSD tests revealed that 
patients with AD were severely impaired in the case of new associations (acquired 
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patients with early AD were able to learn stimulus-response associations using trial-by-trial 
feedback following decisions but generalization of these associations, as measured by 
acquired equivalence, was impaired (Figure 4). The card pairing test revealed that the patients 
with AD showed lower performance than controls in the case of old and new associations, 
which means when stimulus-response associations must be used in a situation requiring 
flexible declarative knowledge, AD patients were impaired, too. 
Figure 4. Performance in the transfer phase of the task (immediate and delayed testing). Old associations refer to 
fish-face pairs exposed in the training phase. New associations refer to never trained pairs learned during 
acquired equivalence. Error bars indicate 95% confidence intervals. 
 
4. Visuospatial abilities in AD and FTD. Results in the visuospatial assessement 
revealed that on quantitative analysis of CDT control group had significantly higher scores 
than the FTD and AD groups (the adjusted means for the control, FTD, and AD groups were 
9.6 (SE=5.38), 7.62 (SE=5.33), and 5.53 (SE= 5 .48), respectively). The FTD group had 
significantly higher scores than the AD group. On qualitative error analysis the groups 
differed significantly in graphic, stimulus bound, conceptual, and spatial or planning errors 
(Figure 5). Comparisons between the dementia groups showed significantly fewer errors in 
stimulus bound responses, conceptual deficits, and spatial or planning errors, in FTD patients 
compared to the AD group. Subanalysis of stimulus-bound responses showed significantly 
fewer errors in the FTD group compared to the AD group in “frontal pull” and stimulus bound 
responses that are also rated as conceptual errors. Subanalysis of conceptual errors showed 
significantly fewer errors in misrepresentation of time, in FTD patients compared to the AD 
group. No difference in misrepresentation of clock face was found between the groups. 
Subanalysis of spatial or planning errors showed significantly more errors in the spatial layout 
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of numbers and numbers outside the clock, in AD patients compared to the FTD group. There 
was no difference between the groups in neglect of the left hemisphere, gaps before 12, 3, 6, 
and 9, and numbers arranged counter-clockwise. The control group made significantly less 
errors in graphic difficulty, fewer stimulus-bound responses, conceptual deficits, and spatial 
or planning errors compared to both FTD and AD patients. The AD group also made more 
perseverative errors compared to the control group. Overall, both quantitative and qualitative 
analyses of CDT differentiated between AD and FTD at the group level. 
Figure 5. Percentage of control individuals (n=25) and FTD (n=36) and AD (n=25) patients making different 
kinds of qualitative errors. 
 
 
Conclusions 
One of the most important questions in clinical neuroscience and neuropsychology is 
whether it is possible to selectively assess certain cognitive function and whether these 
functions can be disrupted in a circumscribed manner in neuropsychiatric diseases. This is the 
issue of domain specificity vs. non-specificity and selective vs. generalized cognitive deficits. 
In the first part of our experiments, we investigated feedback-guided learning of 
stimulus-response associations in PD and AD emphasizing three putatively specific functions: 
(i) effect of positive vs. negative feedback, (ii) generalization of associations (acquired 
equivalence), and (iii) flexibility of stimulus-response association. In the second part of the 
experiments, we investigated how CDT, a widely used classic neuropsychological test, is able 
to separate different cognitive domains (visuospatial functions, verbal comprehension, and 
executive functions) and how it can be used for the differentiation of AD and FTD. 
Regarding positive vs. negative feedback (reward vs. punishment) we found a 
convincing dissociation: PD patients showed reward learning deficit and intact punishment 
learning, which was reversed by pharmacological manipulation. Stimulus-response learning 
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and generalization were also dissociated; moreover, in patients with AD the retrieval of 
successfully learned stimulus-response associations was impaired in a context requiring 
cognitive flexibility. However, in the case of CDT domain specificity was not clear: this test 
includes many overlapping cognitive functions that can be separated only partly by scoring 
different types of errors. 
The main conclusion is that novel neuropsychological tools must be more carefully 
designed, taking into consideration recent advances in cognitive neuroscience. The stimulus-
response learning paradigms introduced in this thesis might represent good examples for such 
developments. We propose that by the application of these novel methods in clinical practice, 
domain-specific alterations can be detected in early phases of neuropsychiatric disorders, 
which may facilitate timely and objective diagnosis and help avoid delays in treatment 
administration. 
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